Corneal Dystrophies, Hereditary
Recent clinical, regulatory, research and industry developments relating to this disease.
HIV and antiretroviral therapy-related fat alterations.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes1
- Oxidative Stress1
Leading journals2
- Nature reviews. Disease primers1
- Oxidative medicine and cellular longevity1
Leading researchers8
- Brown TT1
- Calmy A1
- Capeau J1
- Domingo P1
- Falutz J1
- Grzybowski A1
- Koethe JR1
- Lagathu C1
Affiliations (unnormalised)6
- Department of Medicine McGill University Health Center1
- Domestic and Specialized Medicine Centre "Dilmed"1
- Geneva University Hospitals1
- Hospital de la Santa Creu i Sant Pau1
- Johns Hopkins University1
- Poznan City Hospital1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.